Avidity Partners Management’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,790,000
Closed -$38.3M – 116
2021
Q4
$38.3M Sell
1,790,000
-608,000
-25% -$12M 0.81% 41
2021
Q3
$44.3M Buy
+2,398,000
New +$48.3M 0.98% 33

Other funds holding OCDX

Avidity Partners Management's OCDX Position: Q1 2022 in Review

Avidity Partners Management sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q1 2022, closing a stake of 1,790,000 shares — an estimated $38.3M sold.

Avidity Partners Management first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $44.3M in Q3 2021. 169 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Avidity Partners Management reported no remaining Ortho Clinical Diagnostics Holdings position as of Q1 2022 after selling out during the quarter.
  • Avidity Partners Management sold 1,790,000 Ortho Clinical Diagnostics Holdings shares in Q1 2022, an estimated $38.3M.
  • Avidity Partners Management first reported a position in Ortho Clinical Diagnostics Holdings in Q3 2021 and held it in 2 quarters.
  • Avidity Partners Management's Ortho Clinical Diagnostics Holdings position peaked at $44.3M in Q3 2021.
  • 169 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q1 2022.

Based on Avidity Partners Management's 13F filing for Q1 2022, filed 16 May 2022.